Suppr超能文献

COVID-19 重症患者死亡的危险因素:一项多中心回顾性病例对照研究。

Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study.

机构信息

The First School of Clinical Medicine, Southern Medical University, Guangzhou, 510010, China.

Department of Critical Care Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, 510010, China.

出版信息

BMC Infect Dis. 2021 Jun 24;21(1):602. doi: 10.1186/s12879-021-06300-7.

Abstract

BACKGROUND

Coronavirus disease 2019 (COVID-19) has spread around the world, until now, the number of positive and death cases is still increasing. Therefore, it remains important to identify risk factors for death in critically patients.

METHODS

We collected demographic and clinical data on all severe inpatients with COVID-19. We used univariable and multivariable Cox regression methods to determine the independent risk factors related to likelihood of 28-day and 60-day survival, performing survival curve analysis.

RESULTS

Of 325 patients enrolled in the study, Multi-factor Cox analysis showed increasing odds of in-hospital death associated with basic illness (hazard ratio [HR] 6.455, 95% Confidence Interval [CI] 1.658-25.139, P = 0.007), lymphopenia (HR 0.373, 95% CI 0.148-0.944, P = 0.037), higher Sequential Organ Failure Assessment (SOFA) score on admission (HR 1.171, 95% CI 1.013-1.354, P = 0.033) and being critically ill (HR 0.191, 95% CI 0.053-0.687, P = 0.011). Increasing 28-day and 60-day mortality, declining survival time and more serious inflammation and organ failure were associated with lymphocyte count < 0.8 × 109/L, SOFA score > 3, Acute Physiology and Chronic Health Evaluation II (APACHE II) score > 7, PaO2/FiO2 < 200 mmHg, IL-6 > 120 pg/ml, and CRP > 52 mg/L.

CONCLUSIONS

Being critically ill and lymphocyte count, SOFA score, APACHE II score, PaO2/FiO2, IL-6, and CRP on admission were associated with poor prognosis in COVID-19 patients.

摘要

背景

2019 年冠状病毒病(COVID-19)在全球范围内传播,截至目前,阳性病例和死亡人数仍在不断增加。因此,确定危重症患者死亡的危险因素仍然很重要。

方法

我们收集了所有 COVID-19 重症住院患者的人口统计学和临床数据。我们使用单变量和多变量 Cox 回归方法确定与 28 天和 60 天生存率相关的独立危险因素,并进行生存曲线分析。

结果

在纳入研究的 325 名患者中,多因素 Cox 分析显示,基础疾病(危险比 [HR] 6.455,95%置信区间 [CI] 1.658-25.139,P=0.007)、淋巴细胞减少症(HR 0.373,95%CI 0.148-0.944,P=0.037)、入院时更高的序贯器官衰竭评估(SOFA)评分(HR 1.171,95%CI 1.013-1.354,P=0.033)和危重症患者(HR 0.191,95%CI 0.053-0.687,P=0.011)与住院期间死亡的几率增加相关。淋巴细胞计数<0.8×109/L、SOFA 评分>3、急性生理学和慢性健康评估 II(APACHE II)评分>7、PaO2/FiO2<200mmHg、IL-6>120pg/ml 和 CRP>52mg/L 与 28 天和 60 天死亡率增加、生存时间缩短以及更严重的炎症和器官衰竭相关。

结论

危重症以及入院时的淋巴细胞计数、SOFA 评分、APACHE II 评分、PaO2/FiO2、IL-6 和 CRP 与 COVID-19 患者的不良预后相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b22c/8228930/337c022d729f/12879_2021_6300_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验